Christian H. Geisler

Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies

Andreas Agathangelidis, Nikos Darzentas, Anastasia Hadzidimitriou et al. · Blood · 2012 · 387 citations · Full text

Life Sciences, Immunology, Oncology +17

Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial

Mohammed Farooqui, Janet Valdez, Sabrina Martyr et al. · The Lancet Oncology · 2014 · 366 citations · Full text

Medicine, Immunology, Oncology +11

Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study

Inhye E. Ahn, Mohammed Farooqui, Xin Tian et al. · Blood · 2018 · 204 citations · Full text

Medicine, Pharmacology, Pharmacodynamics +4

Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study

Franco Pandolfi, Thomas P. Loughran, Gordon Starkebaum et al. · Cancer · 1990 · 164 citations · Full text

Medicine, Hematology, Pathology +13

SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma – a Nordic Lymphoma Group study

Lena Nordström, Sandra Sernbo, Patrik Edén et al. · British Journal of Haematology · 2014 · 134 citations

Medicine, Hematology, Oncology +13